Profusa (PFSA) Short-term Investments (2025)
Profusa (PFSA) posted quarterly Short-term Investments of $1751.0 for Q2 2025, down 90.51% quarter-over-quarter from $18450.0 in Q1 2025.
Profusa (PFSA) Short-term Investments (2025) Analysis & Trends
Profusa's Short-term Investments history runs 1 years deep, the most recent figure standing at $1751.0 for Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Profusa | 92,085.85 | -282,914.15 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1,751.00 |
| Mar 31, 2025 | 18,450.00 |